Table 1. Expression of GPCR genes encoding potential therapeutic targets for retinal degeneration in the Abca4−/− Rdh8−/− mouse model of bright light–induced retinopathy.
Gene* | Mouse retina (FPKM) | Human retina (FPKM) | Receptor | G protein signaling | Agonist | Antagonist |
---|---|---|---|---|---|---|
Drd4 | 241.78 | 139.49 | Dopamine receptor D4 | Gi | + | |
Gabbr1 | 40.24 | 35.38 | γ-Aminobutyric acid B receptor 1 | Gi | + | |
Drd2 | 23.1 | 26.33 | Dopamine receptor D2 | Gi | + | |
Adora1 | 18.26 | 13.55 | Adenosine A1 receptor | Gi | + | |
Crhr1 | 6.49 | 12.76 | Corticotropin-releasing hormone receptor 1 | Gs | + | |
S1pr1 | 11.21 | 11.78 | Sphingosine-1-phosphate receptor 1 | Gi | + | |
Drd1a | 9.49 | 8.45 | Dopamine receptor D1a | Gs | + | |
Smo | 6.35 | 5.91 | Smoothened | Gi | + | |
Ednrb | 1.94 | 5.77 | Endothelin receptor type B | Gq | + | |
Grm1 | 3.52 | 4.97 | Metabotropic glutamate receptor 1 | Gq | + | |
Adrb1 | 20.18 | 3.84 | β1-Adrenergic receptor | Gs | + | |
Adora2b | 2.53 | 3.83 | Adenosine A2B receptor | Gs and Gq | + | |
Hrh3 | 19.12 | 3.75 | Histamine receptor H3 | Gi | + | |
Grm4 | 4.93 | 3.1 | Metabotropic glutamate receptor 4 | Gi | + | |
Grm8 | 6.43 | 2.04 | Metabotropic glutamate receptor 8 | Gi | + | |
Grm7 | 3.95 | 1.16 | Metabotropic glutamate receptor 7 | Gi | + | |
Adra1a † | 0.45 | 0.20 | α1A-Adrenergic receptor | Gq | ||
Adra1b † | 1.60 | 1.12 | α1B-Adrenergic receptor | Gq | ||
Adra1d † | 1.72 | 1.08 | α1D-Adrenergic receptor | Gq | ||
Adrb2 | 1.03 | 0.98 | β2-Adrenergic receptor | Gs | + | |
Tacr1 | 2.06 | 0.95 | Tachykinin receptor 1 | Gq | + | |
Ptger1 | 14.88 | 0.94 | Prostaglandin E receptor 1 | Gq | + | |
S1pr2 | 1.13 | 0.63 | Sphingosine-1-phosphate receptor 2 | Gq, Gs, and Gi |
Genes in bold, italicized font encode receptors targeted by the drugs displaying efficacy in this study.
Data from previous study (23).